CN Patent
CN120004750B — 一种无菌的双他喷他多癸二酸酯及其制备方法与用途
Assigned to Anhui Yipuke Pharmaceutical Technology Development Co ltd · Expires 2025-08-08 · 1y expired
What this patent protects
本发明涉及一种无菌双他喷他多癸二酸酯、其制备方法、并包含其药物制剂的医药用途。其中,无菌双他喷他多癸二酸酯的粒径D50为0.5~10μm。本发明还提供了双他喷他多癸二酸酯在用于制备各种急慢性疼痛药物中的用途,其具有显著的长效特点。
USPTO Abstract
本发明涉及一种无菌双他喷他多癸二酸酯、其制备方法、并包含其药物制剂的医药用途。其中,无菌双他喷他多癸二酸酯的粒径D50为0.5~10μm。本发明还提供了双他喷他多癸二酸酯在用于制备各种急慢性疼痛药物中的用途,其具有显著的长效特点。
Drugs covered by this patent
- Tegretol (carbamazepine) · Novartis AG (originally Geigy)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.